Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Melatonin in Alzheimer’s Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer’s Neuropathology
Md. Farhad Hossain, Md. Sahab Uddin, G. M. Sala Uddin, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 12, pp. 8255-8276
Closed Access | Times Cited: 125

Showing 1-25 of 125 citing articles:

Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects
Md. Mominur Rahman, Md. Saidur Rahaman, Md. Rezaul Islam, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 233-233
Open Access | Times Cited: 537
Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer’s disease
Yuanming Li, Jing Zhang, Jiale Wan, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110887-110887
Open Access | Times Cited: 141
Glial cells in Alzheimer’s disease: From neuropathological changes to therapeutic implications
Md. Sahab Uddin, Lee Wei Lim
Ageing Research Reviews (2022) Vol. 78, pp. 101622-101622
Closed Access | Times Cited: 91
Neuroinflammation: A Potential Risk for Dementia
Md Afroz Ahmad, Ozaifa Kareem, Mohammad Khushtar, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 616-616
Open Access | Times Cited: 87
Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
Rammohan V. Rao, Kaavya G. Subramaniam, Julie Gregory, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1659-1659
Open Access | Times Cited: 57
Significance of Melatonin in the Regulation of Circadian Rhythms and Disease Management
K. B. Megha, A. Arathi, Saini Shikha, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 8, pp. 5541-5571
Closed Access | Times Cited: 18
Pharmacological enhancement of slow-wave activity at an early disease stage improves cognition and reduces amyloid pathology in a mouse model of Alzheimer’s disease
Sedef Kollarik, Dorita Bimbiryte, Aakriti Sethi, et al.
Frontiers in Aging Neuroscience (2025) Vol. 16
Open Access | Times Cited: 2
Advancements in nanotherapeutics for Alzheimer’s disease: current perspectives
Seetha Harilal, Jobin Jose, Della Grace Thomas Parambi, et al.
Journal of Pharmacy and Pharmacology (2019) Vol. 71, Iss. 9, pp. 1370-1383
Open Access | Times Cited: 136
Molecular Mechanisms of ER Stress and UPR in the Pathogenesis of Alzheimer’s Disease
Md. Sahab Uddin, Devesh Tewari, Gaurav Sharma, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 7, pp. 2902-2919
Closed Access | Times Cited: 135
Emerging promise of sulforaphane-mediated Nrf2 signaling cascade against neurological disorders
Md. Sahab Uddin, Abdullah Al Mamun, Md. Jakaria, et al.
The Science of The Total Environment (2019) Vol. 707, pp. 135624-135624
Closed Access | Times Cited: 132
Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases
Fang Luo, Aaron F. Sandhu, Wiramon Rungratanawanich, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7174-7174
Open Access | Times Cited: 129
Circadian and sleep dysfunction in Alzheimer’s disease
Md. Sahab Uddin, Devesh Tewari, Abdullah Al Mamun, et al.
Ageing Research Reviews (2020) Vol. 60, pp. 101046-101046
Closed Access | Times Cited: 128
Emerging Signal Regulating Potential of Genistein Against Alzheimer’s Disease: A Promising Molecule of Interest
Md. Sahab Uddin, Md. Tanvir Kabir
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 107
Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning
Md. Tanvir Kabir, Md. Sahab Uddin, Mst. Marium Begum, et al.
Current Pharmaceutical Design (2019) Vol. 25, Iss. 33, pp. 3519-3535
Closed Access | Times Cited: 106
Neuroprotective role of polyphenols against oxidative stress-mediated neurodegeneration
Md. Sahab Uddin, Abdullah Al Mamun, Md. Tanvir Kabir, et al.
European Journal of Pharmacology (2020) Vol. 886, pp. 173412-173412
Open Access | Times Cited: 101
Pharmacological approaches to mitigate neuroinflammation in Alzheimer’s disease
Md. Sahab Uddin, Md. Tanvir Kabir, Abdullah Al Mamun, et al.
International Immunopharmacology (2020) Vol. 84, pp. 106479-106479
Closed Access | Times Cited: 97
NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy
Md. Tanvir Kabir, Mohammad Abu Sufian, Md. Sahab Uddin, et al.
Current Pharmaceutical Design (2019) Vol. 25, Iss. 33, pp. 3506-3518
Closed Access | Times Cited: 95
Neurocognitive effects of melatonin treatment in healthy adults and individuals with Alzheimer’s disease and insomnia: A systematic review and meta-analysis of randomized controlled trials
Dewan Md. Sumsuzzman, Jeong‐Hyun Choi, Yunho Jin, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 127, pp. 459-473
Open Access | Times Cited: 87
Emerging signal regulating potential of small molecule biflavonoids to combat neuropathological insults of Alzheimer's disease
Md. Sahab Uddin, Md. Tanvir Kabir, Devesh Tewari, et al.
The Science of The Total Environment (2019) Vol. 700, pp. 134836-134836
Closed Access | Times Cited: 81
Bergapten: A review of its pharmacology, pharmacokinetics, and toxicity
Youdan Liang, Long Xie, Kai Liu, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 11, pp. 6131-6147
Closed Access | Times Cited: 64
Multifaceted role of polyphenols in the treatment and management of neurodegenerative diseases
Fahadul Islam, Md. Mohaimenul Islam, Atkia Farzana Khan Meem, et al.
Chemosphere (2022) Vol. 307, pp. 136020-136020
Closed Access | Times Cited: 46
A Growing Link between Circadian Rhythms, Type 2 Diabetes Mellitus and Alzheimer’s Disease
Xuemin Peng, Rongping Fan, Lei Xie, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 504-504
Open Access | Times Cited: 43
Exploring the role of COX-2 in Alzheimer's disease: Potential therapeutic implications of COX-2 inhibitors
Nathalie Moussa, Ninar Dayoub
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 9, pp. 101729-101729
Open Access | Times Cited: 29
Anti-inflammatory role of gold nanoparticles in the prevention and treatment of Alzheimer's disease
Munire Aili, Kebing Zhou, Jun Zhan, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 36, pp. 8605-8621
Open Access | Times Cited: 26
Evaluation and targeting of amyloid precursor protein (APP)/amyloid beta (Aβ) axis in amyloidogenic and non-amyloidogenic pathways: A time outside the tunnel
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Ageing Research Reviews (2023) Vol. 92, pp. 102119-102119
Closed Access | Times Cited: 24
Page 1 - Next Page

Scroll to top